Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.
about
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Multiple myeloma in the marrow: pathogenesis and treatments.Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.Natural Killer T Cells in Cancer ImmunotherapyGlioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2.Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin's lymphoma.
P2860
Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Stimulation of invariant natur ...... e 5T33 multiple myeloma model.
@en
type
label
Stimulation of invariant natur ...... e 5T33 multiple myeloma model.
@en
prefLabel
Stimulation of invariant natur ...... e 5T33 multiple myeloma model.
@en
P2093
P2860
P356
P1476
Stimulation of invariant natur ...... e 5T33 multiple myeloma model.
@en
P2093
Domenico Ribatti
Elke De Bruyne
Els Van Valckenborgh
Haneen Nur
Hendrik De Raeve
Josué Kunjom Mfopou
Karin Vanderkerken
Luigia Rao
Maria Antonia Frassanito
P2860
P304
P356
10.1111/BJH.13092
P407
P577
2014-08-21T00:00:00Z